NCT03847311 2025-01-09
Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer Patients
University of Arizona
Phase 2 Completed
Clinical Trials
3 trialsNCT06557330 2025-01-06
MRD Guided De-intensification of Bendamustine/Rituximab for Indolent Non-Hodgkin Lymphoma
Fox Chase Cancer Center
Phase 2 Not yet recruiting
NCT02456363 2015-05-28
Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis
Chung Shan Medical University
Phase 2 Unknown